News
Oct 14, 2024:
Instanosis was selected as a company in NIH Innovation Pavilion at the MedTech Conference.
July 30 – Aug 1, 2024:
Instanosis exhibited at the Association for Diagnostics & Laboratory Medicine (ADLM) 2024 Clinical Lab Expo from July 30th to August 1st in Chicago, IL. ADLM is a global conference which hosts leaders in clinical chemistry, molecular diagnostics, and other areas of breaking science in laboratory medicine.
May 17, 2024:
Instanosis published a new research paper on a novel chemiluminescence assay for the rapid and sensitive detection of fentanyl. The work is done through a multi-institutional collaboration including Instanosis Inc., the University of Pennsylvania, Mayo Clinic, and ATGC Inc.
April 15, 2024:
Instanosis announces the FDA clearance of InstaStrip Fentanyl. The product is a dipstick test for the qualitative detection of Fentanyl in human urine. InstaStrip Fentanyl is both CLIA-Waived and OTC compliant. The kit detect Fentanyl in human urine at a cutoff of 1 ng/mL.
March 18, 2024:
Instanosis has been awarded a new NIH Blue Print Medtech Small Business Translator SBIR grant for developing a rapid urine xylazine test device.
March 18, 2024:
Instanosis has been awarded a new NIH fast track SBIR grant for developing a rapid urine fentanyl test device.
October 24, 2023:
Instanosis’s InstaStrip-Fentanyl Rapid Test has been granted Breakthrough Device designation by the United States Food and Drug Administration (FDA).
June 20, 2023:
Instanosis has successfully implemented Quality Management System, compliant with FDA requirements
June 16, 2023:
Instanosis is awarded a Small Business Innovation Research grant supplement from the NIH to develop lateral flow assays for rapid fentanyl detection
June 06, 2023:
Instanosis is awarded a Small Business Technology Transfer Grant from the NIH to use smartphones to reduce prostate cancer monitoring disparities
August 22, 2022:
Instanosis is awarded a Small Business Innovation Research Grant from the NIH to develop lateral flow assays for rapid fentanyl detection